Welcome to electronic invoicing for GSK Vaccines
As part of GSK's Procure-to-Pay strategy that started a few years ago, GSK Vaccines has been moving to electronic invoicing in order to receive 100% of its incoming invoices via e-invoicing.
As part of GSK's Procure-to-Pay strategy that started a few years ago, GSK Vaccines has been moving to electronic invoicing in order to receive 100% of its incoming invoices via e-invoicing.
Our Integrated Solution is designed for organisations that send a high volume of invoices. It offers a fully automated process that extracts invoice data directly from your billing system and delivers it directly into your buyers’ finance systems. We then process, translate, enrich and validate the data before delivering your invoice directly to your Buyers in any country in the world.